Advanced search
Publication Cover
Nanomedicine Volume 17, 2022 - Issue 23
Submit an article Journal homepage
106
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Advancements in Nanotherapeutics Targeting Senescence in Chronic Obstructive Pulmonary Disease

Keshav Raj Paudel1 Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, 2007, AustraliaORCID Iconhttps://orcid.org/0000-0002-3591-2080View further author information
ORCID Icon,
Meenu Mehta2 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, 2007, AustraliaORCID Iconhttps://orcid.org/0000-0001-8174-5781View further author information
ORCID Icon,
Shakti Dhar Shukla2 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, 2007, Australia;3 Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, 2007, Ultimo, AustraliaORCID Iconhttps://orcid.org/0000-0002-5796-0171View further author information
ORCID Icon,
Nisha Panth1 Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, 2007, AustraliaORCID Iconhttps://orcid.org/0000-0003-0860-6800View further author information
ORCID Icon,
Dinesh Kumar Chellappan4 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, MalaysiaORCID Iconhttps://orcid.org/0000-0001-5567-6663View further author information
ORCID Icon,
Kamal Dua2 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, 2007, Australia;3 Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, 2007, Ultimo, AustraliaORCID Iconhttps://orcid.org/0000-0002-7507-1159View further author information
ORCID Icon &
Philip Hansbro1 Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, 2007, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4741-3035View further author information
ORCID Icon show all
Pages 1757-1760 | Received 10 Oct 2021, Accepted 10 Jan 2022, Published online: 21 Jan 2022

References

  • Mehta M , SatijaS, PaudelKRet al. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: current status and future perspectives. Nanomedicine31, 102303 (2021).
  • Mehta M , DhanjalDS, PaudelKRet al. Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update. Inflammopharmacology28(4), 795–817 (2020).
  • Viegi G , MaioS, FasolaS, BaldacciS. Global burden of chronic respiratory diseases. J. Aerosol Med. Pulm. Drug Deliv.33(4), 171–177 (2020).
  • Campisi J , d’Addadi Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol.8(9), 729–740 (2007).
  • Barnes PJ , BakerJ, DonnellyLE. Cellular senescence as a mechanism and target in chronic lung diseases. Am. J. Respir. Crit. Care Med.200(5), 556–564 (2019).
  • Baker JR , VuppusettyC, ColleyTet al. Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells. Sci. Rep.6, 35871 (2016).
  • Mohamed A , KundaNK, RossK, HutcheonGA, SaleemIY. Polymeric nanoparticles for the delivery of miRNA to treat chronic obstructive pulmonary disease (COPD). Eur. J. Pharm. Biopharm.136, 1–8 (2019).
  • Tsuji T , AoshibaK, NagaiA. Alveolar cell senescence in patients with pulmonary emphysema. Am. J. Respir. Crit. Care Med.174(8), 886–893 (2006).
  • Prasad M , LambeUP, BrarBet al. Nanotherapeutics: an insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed. Pharmacother.97, 1521–1537 (2018).
  • Kim EC , KimJR. Senotherapeutics: emerging strategy for healthy aging and age-related disease. BMB Rep.52(1), 47–55 (2019).
  • Mullard A . Anti-ageing pipeline starts to mature. Nat. Rev. Drug Discov.17(9), 609–612 (2018).
  • Dua K , MalylaV, SinghviGet al. Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems. Chem. Biol. Interact.299, 168–178 (2019).
  • Ng PQ , LingLSC, ChellianJet al. Applications of nanocarriers as drug delivery vehicles for active phytoconstituents. Curr. Pharm. Des.26(36), 4580–4590 (2020).
  • Agostini A , MondragónL, BernardosAet al. Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles. Angew. Chem. Int. Ed. Engl.51(42), 10556–10560 (2012).
  • Zhong Q , MerkelOM, ReinekeJJ, da RochaSRP. Effect of the route of administration and PEGylation of poly(amidoamine) dendrimers on their systemic and lung cellular biodistribution. Mol. Pharm.13(6), 1866–1878 (2016).
  • Lewinska A , Adamczyk-GrochalaJ, BloniarzDet al. AMPK-mediated senolytic and senostatic activity of quercetin surface functionalized Fe3O4 nanoparticles during oxidant-induced senescence in human fibroblasts. Redox Biol.28, 101337 (2020).
  • Mohamed A , PekozAY, RossK, HutcheonGA, SaleemIY. Pulmonary delivery of nanocomposite microparticles (NCMPs) incorporating miR-146a for treatment of COPD. Int. J. Pharm.569, 118524 (2019).
  • Amore E , FerraroM, MancaMLet al. Mucoadhesive solid lipid microparticles for controlled release of a corticosteroid in the chronic obstructive pulmonary disease treatment. Nanomedicine (Lond.)12(19), 2287–2302 (2017).
  • Duan WX , HeMD, MaoLet al. NiO nanoparticles induce apoptosis through repressing SIRT1 in human bronchial epithelial cells. Toxicol. Appl. Pharmacol.286(2), 80–91 (2015).
  • Bhushan B , GopinathP. Antioxidant nanozyme: a facile synthesis and evaluation of the reactive oxygen species scavenging potential of nanoceria encapsulated albumin nanoparticles. J. Mater. Chem. B3(24), 4843–4852 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.